CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is proud to introduce ...

Vaxxas, a clinical-stage biotechnology company, has expanded its global intellectual property portfolio to 42 patents, supporting its exclusive claim to manufacture and sell its proprietary ...